The messenger RNA (mRNA) expression of the four CLRs in bladder cancer primary tumor tissues and normal tissues was first evaluated using a sample comprising 408 primary tumor tissues and 19 normal bladder tissues. This evidence concerns the gene LARS1 and urinary bladder cancer.